3182:HK:HK-W.I.S.E-Nasdaq Overseas China New Econ Co Top 50 Idx Tracker (HKD)

ETF | Others |

Last Closing

USD 12.27

Change

+0.04 (+0.33)%

Market Cap

N/A

Volume

200.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.20 (+0.82%)

USD 159.33B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+0.60 (+0.66%)

USD 30.56B
2801:HK iShares Core MSCI China ETF

+0.34 (+1.37%)

USD 22.44B
2823:HK iShares FTSE A50 China

-0.05 (-0.35%)

USD 17.65B
83188:HK ChinaAMC CSI 300 Index ETF

-0.26 (-0.62%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

N/A

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

-0.03 (-0.24%)

USD 9.22B
82822:HK CSOP FTSE China A50

-0.02 (-0.16%)

USD 8.59B
9010:HK iShares Core MSCI AC Asia ex J..

+0.07 (+0.89%)

USD 3.03B

ETFs Containing 3182:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.89% 85% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.89% 85% B 82% B
Trailing 12 Months  
Capital Gain 37.17% 80% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.17% 79% B- 77% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -3.08% 52% F 50% F
Dividend Return -3.08% 50% F 45% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.60% 69% C- 87% B+
Risk Adjusted Return -21.12% 50% F 41% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.